Why is shared decision making particularly important for 'C' and 'I' recommendations?

• A. Because they involve smaller or uncertain net benefits and depend on patient values.
• B. Because they have large net benefits.
• C. Because they are not evidence-based.
• D. Because they are always refused by patients.

Answer: (A)

Shared decision making is essential when the estimated net benefit is small or uncertain and when outcomes depend heavily on what matters to the patient. For USPSTF, a C recommendation means the net benefit is small after considering harms, and an I statement means there isn't enough evidence to assess the balance of benefits and harms. In both cases, individual patient values, preferences, and risk tolerance drive the actual decision, so a clinician-patient discussion helps tailor what to do.

Think of it this way: the value of acting (screening or preventive service) isn’t clear-cut in these scenarios, so patients may weigh potential harms—like false positives, overdiagnosis, or anxiety—differently. Shared decision making ensures that choices align with what the patient cares about, rather than applying a one-size-fits-all approach.

If you consider the other options, they don’t fit because these recommendations aren’t characterized by large net benefits, they aren’t merely lacking evidence, and they aren’t universally refused—each patient’s values and the uncertain or modest benefits shape the decision.